Department awarded RPB grant
The Indiana University School of Medicine has been granted a Challenge Grant by Research to Prevent Blindness (RPB) in the amount of $75,000 a year for four years to support eye research conducted by the Department of Ophthalmology.
This funding has been awarded based on a thorough review of criteria, including the department's research activities, laboratory environment, and clinical and scientific staff, as evaluated by RPB's renowned Scientific Advisory Panel. RPB Challenge Grants encourage growth for emerging eye research programs and recently appointed department chairs. The funds will be deployed at the discretion of the department chair, to provide opportunities for creative planning and research program development that go beyond the scope of restricted project grants.
Indiana University School of Medicine holds one of five RPB Challenge Grants nationwide.
Since it was founded in 1960, RPB has channeled more than $387 million into eye research. As a result, RPB has been identified with nearly every major breakthrough in vision research in that time. For information on RPB's grants program, listings of RPB institutional and individual grantees, and findings generated by these awards, go to www.rpbusa.org.
NIH funding expands collaboration on ocular neovascularizationIndiana University School of Medicine Department of Ophthalmology was awarded a $1.7 million grant from the National Institutes of Health’s National Eye Institute to explore if a unique protein often targeted in cancer treatments can also treat ocular neovascularization.
Read more here.
NIH grant will help attract students to ophthalmology researchThe ophthalmology department received a $250,000 NIH T35 training grant. These funds allow for the creation of short-term positions in laboratories for first-year medical students to learn and work alongside professional researchers.
Read more here.
Professor receives grant
Amir Hajrasouliha, MD, was awarded an IU Health Value Grant for $150,000 over three years for his project “The role of chemerin-CMKLR1 axis in diabetic retinopathy”